Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed the first RNA-based genetic switch that precisely replicates the logical ...
Performance-enhancing peptides are increasingly popular among fitness enthusiasts and biohackers, despite limited human ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results